Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page
- Check5 days agoChange Detected- Revision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.4.2 has been added and Revision: v3.4.1 has been removed.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.0%

- Check63 days agoChange DetectedAdds UI controls to Show glossary and Hide glossary, affecting user interaction but not core content. Updates metadata and labeling, including capitalization in Last Update Submitted that Met QC Criteria, wording for No FEAR Act Data, and a revision bump to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4, which is a minor metadata change with no impact on the study data, eligibility criteria, outcomes, locations, or scheduling. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.